3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Glioma
5
Glioblastoma
4
Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Gliosarcoma
2
Fallopian Tube Neoplasms
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Metastatic Castration-resistant Prostate Cancer
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
poly ICLC
×
Clear all
No trials found.